highly significantp < 0.0001
The perindopril trials demonstrated a highly significant event reduction (OR 0.78; 95% CI: 0.72–0.85; p < 0.0001 (Fig. 4) .
The perindopril trials demonstrated a highly significant event reduction (OR 0.78; 95% CI: 0.72–0.85; p < 0.0001 (Fig. 4) .